330KRW
3.82 BKRW
64.21 BKRW
8.56 M
About POLARIS AI PHARMA CORP
Sector
CEO
Jae-Chul Kim
Headquarters
Hwaseong
Website
Employees (FY)
164
Founded
1998
ISIN
KR7041910001
FIGI
BBG000GYZ1M2
Polaris AI Pharma Corp. engages in the manufacture and supply of pharmaceutical ingredients and fine chemicals. Its products include treatment of alcoholism, anti-inflammatory, analgesics, muscle relaxant, antiseptic, antispasmodics, anti-cataracts, capillary protectant, unnatural amino acid, anti-hepatitis, anti-parkinsonian, antihistamine, nootropic and anti-diabetics. The company was founded on December 17, 1998 and is headquartered in Hwaseong, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 041910 is 8520.00 KRW — it has decreased by 2.52% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange POLARIS AI PHARMA CORP stocks are traded under the ticker 041910.
Yes, you can track POLARIS AI PHARMA CORP financials in yearly and quarterly reports right on TradingView.
Like other stocks, 041910 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade POLARIS AI PHARMA CORP stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 164.00 employees. See our rating of the largest employees — is POLARIS AI PHARMA CORP on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. POLARIS AI PHARMA CORP EBITDA is 7.66 B KRW, and current EBITDA margin is 11.93%. See more stats in POLARIS AI PHARMA CORP financial statements.